NITRIC OXIDE – BIOCHEMICAL MARKER OF TUBERCULOSIS PATHOGENESIS
https://doi.org/10.21292/2075-1230-2017-95-2-45-50
Abstract
About the Authors
M. E. DyakovaRussian Federation
Candidate of Biological Sciences, Senior Researcher,
32, Polytechnicheskaya St., St. Petersburg, 194064
N. P. Alekseeva
Russian Federation
Candidate of Mathematical Sciences, Researcher,
32, Polytechnicheskaya St., St. Petersburg, 194064
D. S. Esmedlyaeva
Russian Federation
Candidate of Biological Sciences, Senior Researcher,
32, Polytechnicheskaya St., St. Petersburg, 194064
T. L. Perova
Russian Federation
Researcher,
32, Polytechnicheskaya St., St. Petersburg, 194064
N. N. Petrischev
Russian Federation
Doctor of Medical Sciences, Professor, Head of Laser Medicine Center,
6-8, Lva Tolstogo St., St. Petersburg, 197022
P. K. Yablonskiy
Russian Federation
Doctor of Medical Sciences, Professor, Director,
2-4, Ligovsky Ave., St. Petersburg, 191036
References
1. Аbdullaev R.Yu., Kaminskaya G.O., Komissarova O.G. Changes in hemostasis system - components of system inflammatory response syndrome in pulmonary tuberculosis. Vrach, 2012, no. 2, pp. 24-28. (In Russ.)
2. Аfanasieva А.N., Odintsova I.N., Udut V.V. Syndrome of endogenous intoxication and systemic inflammatory response: similarity and differences. Anesteziol. i Reanimatol., 2007, no. 4, pp. 67-71. (In Russ.)
3. Dyakova M.E., Zhuravlev V.Yu., Esmedlyaeva D.S., Perova T.L. Enzymes of purine metabolism in immunopathogenesis of fibrous cavernous pulmonary tuberculosis. Med. Immunologiya, 2016, vol. 18, no. 1, pp. 85-90. (In Russ.)
4. Zhigaltsova O.A. Physiological role of α1-antitrypsin and effects of its deficiency. Med. Panorama, 2009, vol. 102, no. 6, pp. 82-84. (In Russ.)
5. Kaminskaya G.O., Аbdullaev R.Yu., Komissarova O.G. Evaluation of the functional state of vascular endothelium in pulmonary tuberculosis patients upon results of biochemical tests. Tub. i Bolezni Legkikh, 2013, no. 2, pp. 42-47. (In Russ.)
6. Krasnov V.А., Zenkov N.K., Kolpakov А.R., Menschikova E.B. Activated oxygen metabolites in case of tuberculosis. Probl. Tub., 2005, no. 9, pp. 9-17. (In Russ.)
7. Bryan N.S., Bian K., Murad F. Discovery of the nitric oxide signaling pathway and targets for drug development. Frontiers in Bioscience, 2009, vol. 14, no. 1, pp. 1-18.
8. Butov D.O., Kuzhko M.M., Kalmykova I.M. et al. Changes in nitric oxide synthase and nitrite and nitrate serum levels in patients with or without MDR-TB undergoing the intensive phase of anti-tuberculosis therapy. Int. J. Mycobacteriol., 2014, no. 3, pp. 139-143.
9. Guzik T.J., Mussa S., Gastaldi D. et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation, 2002, vol. 105, pp. 1656-1662.
10. Ikeda U., Kurosaki K., Ohya K., Shimada K. Adenosine stimulates nitric oxide synthesis in vascular smooth muscle cells. Cardiovasc. Research, 1997, vol. 35, pp. 168-174.
11. Maeda H., Wu J., Okamoto T. et al. Kallikrein-kinin in infection and cancer. Immunopharmacology, 1999, vol. 43, no. 2-3, pp. 115-128.
12. Mir M.M., Khan A.R., Dar N.A., Salahuddin M. Polymorphonuclear leukocyte mediated oxidative inactivation of alpha-1-proteinase inhibitor: modulation by nitric oxide. Indian J. Clin. Biochem., 2005, vol. 20, no. 1, pp. 184-192.
13. Miranda M.S., Wek Rodrigues K., Cordero E.M., Rojas-Espinosa O. Expression of cyclooxygenase-2, alpha 1-acid-glycoprotein and inducible nitric oxide synthase in the developing lesions of murine leprosy. Int. J. Exp. Path., 2006, vol. 87, pp. 485-494. doi: 10.1111/i.1365-2613.2006.00504.x
14. Mitaka C., Hirata Y., Yokoyama K. et al. Relationships of circulating nitrite/nitrate levels to severity and multiple organ dysfunction syndrome in systemic inflammatory response syndrome. Shock, 2003, vol. 19, no. 4, pp. 305-309.
15. Miyamoto Y., Akaike T., Maeda H. S-nitrosylated human alpha(1)-protease inhibitor. Biochim. Biophys. Acta., 2000, vol. 1477, pp. 90-97.
16. Nathan C.F., Hibbs Jr. J.B. Role of Nitric Oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol., 1991, vol. 3, pp. 65-70.
17. Stepuro T.L., Zinchuk V.V. Nitric oxide effect on the hemoglobin-oxygen affinity. J. Physiol. Pharmacol., 2006, vol. 57, no. 1, pp. 29-38.
18. Zanini D., Schmatz R., Pimentel V.C. et al. Lung cancer alters the hydrolysis of nucleotides and nucleosides in platelets. Biomed. Pharmacother., 2012, vol. 66, no. 1, pp. 40-45.
Review
For citations:
Dyakova M.E., Alekseeva N.P., Esmedlyaeva D.S., Perova T.L., Petrischev N.N., Yablonskiy P.K. NITRIC OXIDE – BIOCHEMICAL MARKER OF TUBERCULOSIS PATHOGENESIS. Tuberculosis and Lung Diseases. 2017;95(2):45-50. (In Russ.) https://doi.org/10.21292/2075-1230-2017-95-2-45-50